Growth Metrics

Gilead Sciences (GILD) Gross Profit (2016 - 2025)

Gilead Sciences' Gross Profit history spans 17 years, with the latest figure at $6.3 billion for Q4 2025.

  • For Q4 2025, Gross Profit rose 5.23% year-over-year to $6.3 billion; the TTM value through Dec 2025 reached $23.2 billion, up 3.14%, while the annual FY2025 figure was $23.2 billion, 3.14% up from the prior year.
  • Gross Profit reached $6.3 billion in Q4 2025 per GILD's latest filing, up from $6.2 billion in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $6.3 billion in Q4 2025 to a low of $4.6 billion in Q4 2021.
  • Average Gross Profit over 5 years is $5.4 billion, with a median of $5.3 billion recorded in 2022.
  • Peak YoY movement for Gross Profit: dropped 23.34% in 2021, then increased 29.8% in 2022.
  • A 5-year view of Gross Profit shows it stood at $4.6 billion in 2021, then grew by 29.8% to $6.0 billion in 2022, then dropped by 16.17% to $5.0 billion in 2023, then increased by 19.19% to $6.0 billion in 2024, then increased by 5.23% to $6.3 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Gross Profit are $6.3 billion (Q4 2025), $6.2 billion (Q3 2025), and $5.6 billion (Q2 2025).